The IMC team is committed to combining artificial intelligence and immune biotechnology for the development of antibody drugs, hoping to improve the quality of health and extend active lifespans of humans. Our team possesses core technologies in big data analysis, artificial intelligence prediction, computer-aided drug design, and next-generation gene sequencing.
Ethereum